Cerebral amyloid-β-related angiitis without cerebral microbleeds in a patient with subarachnoid hemorrhage

Cardiovasc Pathol. 2019 Sep-Oct:42:36-40. doi: 10.1016/j.carpath.2019.05.004. Epub 2019 May 25.

Abstract

Amyloid-β-related angiitis (ABRA), a subtype of cerebral amyloid angiopathy (CAA), is vasculitis occurring in relation to amyloid-β (Aβ) deposition in the walls of intracranial blood vessels. ABRA is presumed to be caused by some immune response to the deposited Aβ. An 81-year-old man on oral anticoagulant therapy complained of headache, nausea, and difficulty with standing after a head injury. Head computed tomography revealed subcortical bleeding in the right temporoparietal lobe, and 3 days after admission, magnetic resonance imaging (MRI) showed subarachnoid hemorrhage (SAH) around the hematoma. Cerebral microbleeds, a characteristic of CAA, were not detected on MRI. On worsening of his symptoms, intracranial brain biopsy and hematoma removal were performed. Intraoperative rapid diagnosis with a frozen section suspected vasculitis, which enabled the prompt initiation of steroid therapy. He was pathologically diagnosed with ABRA (granulomatous angiitis) using a formalin-fixed paraffin-embedded section. Vasculitis was prominent around blood vessels in the pia matter covering the cerebrum. In this case, the inflammatory cells seemed to appear via the subarachnoid space following cerebral hemorrhage and SAH. ABRA seemed to be developed by intracranial hemorrhage in this case.

Keywords: Aβ-related angiitis; Cerebral amyloid angiopathy; Cerebral microbleeds; Frozen section diagnosis; Primary CNS vasculitis.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Amyloid beta-Peptides / analysis*
  • Cerebral Amyloid Angiopathy / diagnostic imaging
  • Cerebral Amyloid Angiopathy / drug therapy
  • Cerebral Amyloid Angiopathy / metabolism
  • Cerebral Amyloid Angiopathy / pathology*
  • Cerebral Arteries / chemistry
  • Cerebral Arteries / diagnostic imaging
  • Cerebral Arteries / drug effects
  • Cerebral Arteries / pathology*
  • Glucocorticoids / therapeutic use
  • Humans
  • Male
  • Pia Mater / blood supply*
  • Prednisolone / therapeutic use
  • Subarachnoid Hemorrhage / diagnostic imaging
  • Subarachnoid Hemorrhage / pathology*
  • Subarachnoid Hemorrhage / surgery
  • Treatment Outcome
  • Vasculitis, Central Nervous System / diagnostic imaging
  • Vasculitis, Central Nervous System / drug therapy
  • Vasculitis, Central Nervous System / metabolism
  • Vasculitis, Central Nervous System / pathology*

Substances

  • Amyloid beta-Peptides
  • Glucocorticoids
  • Prednisolone

Supplementary concepts

  • Granulomatous Angiitis of the Central Nervous System